Perrigo Sells Infant Formula Unit
Perrigo has agreed to sell its infant formula business to MeridianMade for up to 175 million dollars. The consumer health company is shifting its focus toward over-the-counter medicines and self-care products. The transaction is expected to close in early 2027.
Xurve View
Insights:
Xurve View
PERRIGO CO PLC will sell its infant formula business to MeridianMade for up to $175M in cash and performance-linked payments, shifting focus to over-the-counter medicines. The deal follows a strategic review launched last year after manufacturing scrutiny and contamination risks. The transaction helps Perrigo divest non-core assets while MeridianMade expands its contract manufacturing footprint.
